March 3, 2026

Safety of Ferric Carboxymaltose in Heart Failure Patients With Iron Deficiency Across Ferritin Levels, Heart Failure Causes, and Prior Hospitalization Status: A Meta-Analysis

Ferric carboxymaltose shows a favorable safety profile in heart failure patients with iron deficiency.
Patients across various ferritin levels experienced minimal adverse events related to the treatment.
Meta-analysis conducted across multiple studies to assess the safety and effectiveness of the intervention.
Findings suggest that ferric carboxymaltose may improve treatment strategies for heart failure patients.

Bookmark

Cite This Study

Elbataa et al. (Tue,) studied this question.

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

Bookmark